Complete ablation of tumors using synchronous chemoradiation with bimetallic theranostic nanoparticles
Open accessThe DOI matches its Crossref record.
Abstract
Synchronous chemotherapy and radiotherapy, termed chemoradiation therapy, is now an important standard regime for synergistic cancer treatment. For such treatment, nanoparticles can serve as improved carriers of chemotherapeutics into tumors and as better radiosensitizers for localized radiotherapy. Herein, we designed a Schottky-type theranostic heterostructure, Bi2S3–Au, with deep level defects (DLDs) in Bi2S3 as a nano-radiosensitizer and CT imaging contrast agent which can generate reactive free radicals to initiate DNA damage within tumor cells under X-ray irradiation. Methotrexate (MTX) was conjugated onto the Bi2S3–Au nanoparticles as a chemotherapeutic agent showing enzymatic stimuli-responsive release behavior. The designed hybrid system also contained curcumin (CUR), which cannot only serve as a nutritional supplement for chemotherapy, but also can play an important role in the radioprotection of normal cells. Impressively, this combined one-dose chemoradiation therapeutic injection of co-drug loaded bimetallic multifunctional theranostic nanoparticles with a one-time clinical X-ray irradiation, completely eradicated tumors in mice after approximately 20 days after irradiation showing extremely effective anticancer efficacy which should be further studied for numerous anti-cancer applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Enhanced In Vivo Radiotherapy of Breast Cancer Using Gadolinium Oxide and Gold Hybrid Nanoparticles
Nosrati, H., Salehiabar, M., Charmi, J., Yaray, K., Ghaffarlou, M., Balcioglu, E., & Ertas, Y. N. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00965 · Cited by 73
Self-citationNosrati, H., Ghaffarlou, M., Salehiabar, M., Mousazadeh, N., Abhari, F., Barsbay, M., Ertas, Y. N., Rashidzadeh, H., Mohammadi, A., Nasehi, L., et al. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213090 · Cited by 60
Self-citationGhaffarlou, M., Mohammadi, A., Mousazadeh, N., Salehiabar, M., Kalantari, Y., Charmi, J., Barsbay, M., Ertas, Y. N., Danafar, H., Rezaeejam, H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40763-9 · Cited by 20
“For this reason, negatively charged NPs cannot electrostatically bind to blood cells and thus have a high circulation time in the blood 28,29 .”
BackgroundMethodSelf-citation
Metadata
- Authors
- Nosrati, H., Attari, E., Abhari, F., Barsbay, M., Ghaffarlou, M., Mousazadeh, N., Vaezi, R., Kavetskyy, T., Rezaeejam, H., Webster, T. J., Johari, B., & Danafar, H.
- Venue
- Bioactive Materials
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 7
- Pages
- 74-84
- ISSN
- 2097-1192 (ISSN-L)
- 2452-199X
- OpenAlex
- W3169406559
- Cited by
- 61
- References
- 0
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Complete ablation of tumors using synchronous chemoradiation with bimetallic theranostic nanoparticles. https://app.cochat.ai/papers/10.1016/j.bioactmat.2021.05.015
- The paper
- Nosrati, H., Attari, E., Abhari, F., Barsbay, M., Ghaffarlou, M., Mousazadeh, N., Vaezi, R., Kavetskyy, T., Rezaeejam, H., Webster, T. J., Johari, B., & Danafar, H. (2022). Complete ablation of tumors using synchronous chemoradiation with bimetallic theranostic nanoparticles. Bioactive Materials. https://doi.org/10.1016/j.bioactmat.2021.05.015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.